研究报告 |
|
|
|
|
shRNA靶向干扰COX-2抑制人肝癌裸鼠皮下移植瘤及其血管生成 |
陈光辉1, 刘预2, 孔飞飞1, 邱欣欣1, 成凤1, 匡文斌1, 李朴1, 涂植光1 |
1. 重庆医科大学医学检验系 临床检验诊断学教育部重点实验室 重庆 400016;
2. 重庆市肿瘤医院临床检验中心 重庆 400030 |
|
Inhibitory Effects of Cyclooxygenase-2 Inhibited by shRNA on the Growth and Angiogenesis of Human Liver Cancer Cell Subcutaneous Xenograft Tumors in Nude Mice |
CHEN Guang-hui1, LIU Yu2, KONG Fei-fei1, QIU Xin-xin1, CHENG Feng1, KUANG Wen-bin1, LI Pu1, TU Zhi-guang1 |
1. Key Laboratory of Laboratory Medical Diagnostics of Ministry of Education, Faculty of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China;
2. Clinical Laboratory Center, Chongqing Tumor Hospital, Chongqing 400030, China |
引用本文:
陈光辉, 刘预, 孔飞飞, 邱欣欣, 成凤, 匡文斌, 李朴, 涂植光. shRNA靶向干扰COX-2抑制人肝癌裸鼠皮下移植瘤及其血管生成[J]. 中国生物工程杂志, 2011, 31(03): 29-34.
CHEN Guang-hui, LIU Yu, KONG Fei-fei, QIU Xin-xin, CHENG Feng, KUANG Wen-bin, LI Pu, TU Zhi-guang. Inhibitory Effects of Cyclooxygenase-2 Inhibited by shRNA on the Growth and Angiogenesis of Human Liver Cancer Cell Subcutaneous Xenograft Tumors in Nude Mice. China Biotechnology, 2011, 31(03): 29-34.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/
或
https://manu60.magtech.com.cn/biotech/CN/Y2011/V31/I03/29
|
[1] Bosch F X, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis, 1999, 19(3): 271-285.
[2] Thomas M B, Zhu A X. Hepatocellular carcinoma:the need for progress. J Clin Oncol, 2005, 23(13): 2892-2899.
[3] Cerveilo M, Foderaa D, Florena, et a1. Correlation between expression of cyelooxygenase-2 and the presence of inflammatory cells in human primary hepatocellular carcinoma:possible role in tumor promotion and angiogenesis. World J Gastroenterol, 2005, 11(30): 4638 -4643.
[4] Cervello M, Montalto G. Cyclooxygenases in hepatocellular carcinoma. World J Gastroenterol, 2006, 12(32): 5113-5121.
[5] Uefuji K, Ichikura T, Mochizuki H. Expression of cyclooxygenase-2 in human gastric adenomas and adenocarcinomas. J Surg Oncol, 2001, 76(1): 26-30.
[6] Zhang H, Sun X F. Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer . Am J Gastroenterol, 2002, 97(4): 1037-1041.
[7] Parrett M L, Haltis R E, Joarder F S, et al. Cyclooxygenase-2 expression in human breast cancer . Int J Oncology, 1997, 10(7): 503-507.
[8] Dohmen K, Okabe H, Ishibashi H. Regression of hepatocellular carcinoma due to cyclooxygenase (COX)-2 inhibitor. Am J Gastroenterol, 2006, 101(10): 2437-2438.
[9] Strillaccit A, Griffoni C, Spisni E, et al. RNA interference as a key to knockdown overexpressed cyclooxygenase-2 gene in tumour cells . Briti J of Can, 2006, 94(9):1300-1310.
[10] Charames G S, Bapat B. Cyclooxygenese-2 knockdown by RNA interference in colon cancer . Int J Oncol, 2006, 28(2): 543-549.
[11] 杨义明,刘预,涂植光,等. 短发夹RNA抑制肝癌细胞HepG2 COX-2基因表达的探讨. 中国肿瘤临床, 2007, 34(10): 566-569. Yang Y M, Liu Y, Tu Z G, et al. Chinese Journal of Clinical Oncology, 2007, 34(10): 566-569.
[12] Soumaoro L T, Uetake H, Takagi Y, et a1. Coexpression of VEGF-C and COX-2 in human colorectal cancer and its association with lymph node metastasis. Dis Colon Rectum, 2006, 49(3): 392-398.
[13] von Rahden B H, Stein H J, Puhringer F, et a1. Coexpression of cyclooxygenases(COX-1, COX-2) and vascular endothelial growth factors(VEGF-A,VEGF-C) in esophageal adenocarcinoma. Cancer Res, 2005, 65(12): 5038-5044.
[14] Joo Y E, Rew J S, Seo Y H, et a1. Cyclooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer. J Clin Gastroenterol, 2003, 37(1): 28-33.
[15] Timoshenko A V, Chakraborty C, Wagner G F, et al. Cox-2 mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer. Briti J Cancer 2006, 94(8): 1154-1163.
[16] Liu H, Yang Y, Xiao J, et al. COX-2-mediated regulation of VEGF-C in association with lymphangiogenesis and lymph node metastasis in lung cancer. Anat Rec, 2010, 293(11): 1838-1846.
[17] Kern M A, Schoneweiss M M, Sahi D, et al. Cyclooxygenase-2 inhibitors suppress the growth of human hepatocellular carcinoma implants in nude mice. Carcinogenesis,2004, 25(7): 1193-1199.
[18] Wang R, Wang X, Lin F, et al. shRNA-targeted Cyclooxygenase (COX)-2 inhibits proliferation, reduces invasion and enhances chemosensitivity in laryngeal carcinoma cells. Mol Cell Biochem, 2008, 317(1-2): 179-188.
[19] Narayanan B A, Narayanan N K, Davis L, et al. RNA interference-mediated cyclooxygenase-2 inhibition prevents prostate cancer cell growth and induces differentiation: modulation of neuronal protein synaptophysin, cyclin D1, and androgen receptor. Mol Cancer Ther, 2006, 5(5): 1117-1125. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|